TABLE 4.
Ability of the bivalent bacterin to prevent Lyme disease-associated joint abnormalities
| Abnormality | No. (%) positive
|
P | |
|---|---|---|---|
| Controls (n = 15) | Bacterin (n = 15) | ||
| Stiffness or lameness | 4 (27) | 0a | 0.0996 |
| Synovitis | 6 (55)b | 0c | 0.0034 |
| Total | 10 (67) | 0 | <0.0001 |
a
Two stiff or lame dogs that received bacterin were not included because spirochetes were not recovered and serologic evidence of B. burgdorferi infection or exposure was not detected.
b
n = 11; the joints from four dogs that developed joint stiffness or lameness were not examined.
c
n = 13; the joints from two dogs that developed joint stiffness or lameness were not examined.